Reliable quantitative evaluation of molecular pathways is critical for both drug discovery and treatment monitoring. We have modified the CAM assay to quantitatively measure vascular density, endothelial proliferation, and changes in protein expression in response to anti-angiogenic and pro-angiogenic agents. This improved CAM assay can correlate changes in vascular density with changes seen on a molecular level. We expect that these described modifications will result in a single in vivo assay system, which will improve the ability to investigate molecular mechanisms underlying the angiogenic response.
- Chorioallantoic membrane (CAM)
- Confocal microscopy
- Layered Expression Scanning (LES)
- XTT assay
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)